Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission.
Short NJ, Macaron W, Kadia T, Dinardo C, Issa GC, Daver N, Wang S, Jorgensen J, Nguyen D, Bidikian A, Patel KP, Loghavi S, Konopleva M, Yilmaz M, Jabbour E, Maiti A, Abbas HA, Shpall E, Popat U, Al-Atrash G, Pierce S, Kantarjian HM, Ravandi F.
Short NJ, et al. Among authors: nguyen d.
Am J Hematol. 2022 Nov;97(11):E408-E411. doi: 10.1002/ajh.26698. Epub 2022 Sep 8.
Am J Hematol. 2022.
PMID: 36054774
Free article.